Pharma OXIT ApS: Financial statements 2022
CVR: 37757292
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pharma OXIT ApS (CVR 37757292) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -16,258 and a net result of DKK -16,275 compared with DKK -5,031 the year before. Equity in the 2022 report amounted to DKK -95,236.
- Gross Profit
- DKK -16,258
- Profit/Loss
- DKK -16,275
- Equity
- DKK -95,236
- Total Assets
- DKK 939
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -16 t. | -16 t. | -95 t. | - |
| 2021 | - | -5 t. | -5 t. | -79 t. | - |
| 2020 | - | -5 t. | -5 t. | -74 t. | - |
| 2019 | - | -10 t. | -17 t. | -69 t. | - |
| 2018 | - | -5 t. | -13 t. | -52 t. | - |
Official annual report
Keep an eye on Pharma OXIT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pharma OXIT ApS has published its annual report for 2021. Gross profit came to DKK -5,000, and the net result was DKK -5,031.
About Pharma OXIT ApS
Pharma OXIT ApS is a Danish company of the type Anpartsselskab based in Knebel, founded in 2016. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Tom Buris Nielsen. The company is owned by Tom Buris Nielsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -7,919 and a net result of DKK -7,939 compared with DKK -7,501 the year before. Equity in the 2025 report amounted to DKK -120,365.